Pages that link to "Q34330164"
Jump to navigation
Jump to search
The following pages link to Signaling pathways activated by daunorubicin (Q34330164):
Displaying 50 items.
- Increased interaction between DJ-1 and the Mi-2/ nucleosome remodelling and deacetylase complex during cellular stress (Q24298251) (← links)
- FADD adaptor in cancer (Q24795895) (← links)
- Dual effect of oxidative stress on leukemia cancer induction and treatment (Q26866544) (← links)
- Molecular requirements for doxorubicin-mediated death in murine oocytes (Q28294027) (← links)
- Targeting NF-kappaB in hematologic malignancies (Q28299055) (← links)
- Human disease-drug network based on genomic expression profiles (Q28475892) (← links)
- Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells (Q28478256) (← links)
- Anthraquinone G503 induces apoptosis in gastric cancer cells through the mitochondrial pathway (Q28543411) (← links)
- Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription (Q28580418) (← links)
- Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis (Q30835959) (← links)
- Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia (Q33415379) (← links)
- A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia (Q33630851) (← links)
- Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells. (Q34168806) (← links)
- Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines (Q34295244) (← links)
- Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis (Q34358774) (← links)
- Preferential induction of apoptosis for primary human leukemic stem cells (Q34415832) (← links)
- Glucosylceramide synthase and apoptosis (Q35047165) (← links)
- Tumor p53 status and response to topoisomerase II inhibitors (Q35091149) (← links)
- Mitochondria as a target for inducing death of malignant hematopoietic cells. (Q35137160) (← links)
- Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms (Q35158082) (← links)
- Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences (Q35177652) (← links)
- Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond (Q35675184) (← links)
- Mitogen-activated protein kinases in apoptosis regulation (Q35743118) (← links)
- Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells (Q35808597) (← links)
- Mechanisms controlling pathogenesis and survival of leukemic stem cells (Q35892084) (← links)
- The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation (Q35964780) (← links)
- Cell death signaling and anticancer therapy (Q35972102) (← links)
- miR-181a modulates acute myeloid leukemia susceptibility to natural killer cells (Q36256357) (← links)
- Early gene expression of acute myeloid leukemia in response to chemotherapy (Q36817144) (← links)
- Molecular mechanisms of drug resistance in acute myeloid leukaemia (Q36835812) (← links)
- The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents (Q37141899) (← links)
- Mapping genes that contribute to daunorubicin-induced cytotoxicity (Q37328312) (← links)
- Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance (Q37723478) (← links)
- Do reactive oxygen species play a role in myeloid leukemias? (Q37852492) (← links)
- Proteomics approaches for myeloid leukemia drug discovery. (Q38042731) (← links)
- Leukemic stem cells: a review (Q38087670) (← links)
- Comparison of in vitro antileukemic activity of obatoclax and ABT-737. (Q38793940) (← links)
- BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1. (Q39036236) (← links)
- Targeting acute myeloid leukemia stem cell signaling by natural products. (Q39109921) (← links)
- Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase s (Q39143241) (← links)
- Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis (Q39187156) (← links)
- Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells (Q39410853) (← links)
- Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation (Q39530217) (← links)
- Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. (Q39723263) (← links)
- NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways (Q39770370) (← links)
- c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia (Q39957937) (← links)
- C18 ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry. (Q39990649) (← links)
- Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. (Q40045975) (← links)
- Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines. (Q40131136) (← links)
- Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs (Q40150799) (← links)